CClinicalTrials.gg
Status unknownNCT04865185Updated Apr 29, 2021

Effect of Topical Lidocaine on Warm and Cold Sensation in Healthy Individuals

An interventional study of Xylocaine spray 100mg/ml and Ethanol in Neuropathy;Peripheral and Thermal Hypesthesia, sponsored by University of Aarhus. Status unknown at 1 site in Denmark. Open to participants aged 18 Years to 40 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2021-04-29.

Sponsored by University of Aarhus · Not applicable, Interventional, and Diagnostic

The sponsor has not verified this record recently (last verified Mar 2021), so the status shown — last known as Recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
18 Years to 40 Years
Sex
All
01

Study summary

The purpose of the present study is to systematically test the occurrence of paradoxical and illusory responses to cold and warm stimuli in healthy volunteers with artificial sensory loss.

Read the detailed description

Efficient thermal sensation is important for adequate behavioral response to cold or warm stimuli and early signs of neuropathy can be changes in the thermal sensation.

Alterations in thermal perception can results in paradoxical heat sensation (a warm perception when the skin is cooled) or a peculiar/burning sensation when the skin is stiumlated with simultaneous warm and cold (a "thermal grill").

Clarifying the occurrence of these paradoxical and illusory sensations, may help understanding early signs of peripheral neuropathy as well as thermal sensory perception.

The investigators plan to conduct a study on thermal sensory perception using a model of sensory loss in healthy volunteers and systematically test the occurrence of paradoxical heat sensations and responses to the thermal grill.

02

Conditions studied

  • Neuropathy;Peripheral
  • Thermal Hypesthesia

Keywords

  • Paradoxical Heat Sensations
  • Thermal Grill Illusion
  • Lidocaine
03

Who can participate

Ages eligible
18 Years to 40 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Healthy subjects
  • Age between 18 and 40 years
  • Participant is able and willing to give informed consent.

Exclusion criteria

Exclusion Criteria:

  • Unable to understand and speak Danish
  • Non-cooperative
  • Chronic pain or acute pain the past week lasting more than 4 hours or pain on the day of investigation
  • Pain medication within the last week
  • Medication within the last week that can affect assessment
  • Psychiatric or neurological disease and diseases that may affect the assessment
  • Sensory disturbances
  • History or symptoms of significant diseases (e.g. psychiatric or neurological disease, diseases that may affect the assessment, sensory disturbances, cancer, diabetes mellitus, liver diseases, kidney diseases, cardiovascular diseases)
  • Pregnancy or lactation
  • Jetlag or sleep deprivation
  • Alcohol or drug abuse
  • Consumption of cannabis the last 4 weeks and consumption of alcohol in the last 48 hours
  • Any abnormality of the skin or of vascular origin at application site
  • History of hypersensitivity to lidocaine, other amide-type anesthetics, or other contents of the lidocaine or vehicle
04

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Double (Participant, Investigator)
Enrollment
60 participants (estimated)

Study arms

  • Active comparator
    Xylocaine spray 100mg/ml

    Topical application

    Diagnostic Test: Xylocaine spray 100mg/ml

  • Placebo comparator
    Ethanol

    Topical application

    Diagnostic Test: Ethanol

Interventions

  • Diagnostic testXylocaine spray 100mg/ml

    Topical application

  • Diagnostic testEthanol

    Topical application

05

What researchers measure

Primary outcomes

  1. Paradoxical heat sensation (PHS)

    Number of PHS responders on arm treated with lidocaine 45 minutes after drug application and Number of PHS responders on arm treated with ethanol 45 minutes after drug application

    Time frame: 45 minutes

Secondary outcomes

  1. Thermal Grill (TG)

    Number of TG responders on arm treated with lidocaine 75 minutes after drug application and Number of TG responders on arm treated with ethanol 75 minutes after drug application

    Time frame: 75 minutes

  2. Quality of the Thermal Grill (TG)

    The participants are asked whether the stimulus is burning, hot, warm, neutral, cold, or freezing cold after the TG-condition (warm and cold), only warm or only cold on arm treated with lidocaine 75 minutes after drug application The participants are asked whether the stimulus is burning, hot, warm, neutral, cold, or freezing cold after the TG-condition (warm and cold) or only warm or only cold on arm treated with ethanol 75 minutes after drug application

    Time frame: 75 minutes

  3. Pain intensity of the Thermal Grill (TG)

    The participants are asked to rate the intensity of pain on a visual analog scale (VAS) 0-100 (0 no pain; 100 worst pain imaginable) after the TG-condition (warm and cold), only warm or only cold on arm treated with lidocaine 90 minutes after drug application The participants are asked to rate the intensity of pain on a VAS 0-100 (0 no pain; 100 worst pain imaginable) after the TG-condition (warm and cold), only warm or only cold on arm treated with ethanol 90 minutes after drug application

    Time frame: 90 minutes

  4. Intensity of unpleasantness of the Thermal Grill (TG)

    The participants are asked to rate the intensity of unpleasantness on a VAS 0-100 (0 no unpleasantness; 100 worst unpleasantness imaginable) after the TG-condition (warm and cold), only warm or only cold on arm treated with lidocaine 95 minutes after drug application The participants are asked to rate the intensity of unpleasantness on a VAS 0-100 (0 no unpleasantness; 100 worst unpleasantness imaginable) after the TG-condition (warm and cold), only warm or only cold on arm treated with ethanol 95 minutes after drug application

    Time frame: 95 minutes

  5. Intensity of cold of the Thermal Grill (TG)

    The participants are asked to rate the intensity of unpleasantness on a VAS 0-100 (0 no cold; 100 extremely cold ) after the TG-condition (warm and cold), only warm or only cold on arm treated with lidocaine 95 minutes after drug application The participants are asked to rate the intensity of unpleasantness on a VAS 0-100 (0 no cold; 100 extremely cold ) after the TG-condition (warm and cold), only warm or only cold on arm treated with ethanol 95 minutes after drug application

    Time frame: 95 minutes

  6. Intensity of warm of the Thermal Grill (TG)

    The participants are asked to rate the intensity of unpleasantness on a VAS 0-100 (0 no warm; 100 extremely warm ) after the TG-condition (warm and cold), only warm or only cold on arm treated with lidocaine 95 minutes after drug application The participants are asked to rate the intensity of unpleasantness on a VAS 0-100 (0 no warm; 100 extremely warm ) after the TG-condition (warm and cold), only warm or only cold on arm treated with ethanol 95 minutes after drug application

    Time frame: 95 minutes

  7. Paradoxical heat sensation (PHS)

    Number of PHS responders at baseline without any treatment, 30 minutes before drug application

    Time frame: 30 minutes before drug application

  8. Thermal Grill (TG)

    Number of TG responders at baseline without any treatment 20 minutes before drug application

    Time frame: 20 minutes before drug application

Other outcomes

  1. Thermal thresholds

    Detection- and pain thresholds for cold, warm (degrees) stimuli at baseline without any treatment Detection- and pain thresholds for cold, warm (degrees) stimuli on arm treated with lidocaine 45 minutes after drug application Detection- and pain thresholds for cold, warm (degrees) stimuli on arm treated with ethanol 45 minutes after drug application

    Time frame: 45 minutes

  2. Paradoxical heat sensation (PHS) using a modified protocol

    Number of PHS responders if the skin is heated or cooled prior the test at baseline without any treatment Number of PHS responders if the skin is heated or cooled prior the test on arm treated with lidocaine 100 minutes after drug application Number of PHS responders if the skin is heated or cooled prior the test on arm treated with ethanol 100 minutes after drug application

    Time frame: 100 minutes

  3. Mechanical thresholds

    Detection- and pain thresholds for mechanical (mNewton) stimuli at baseline without any treatment Detection- and pain thresholds for mechanical (mNewton) stimuli on arm treated with lidocaine 45 minutes after drug application Detection- and pain thresholds for mechanical (mNewton) stimuli on arm treated with ethanol 45 minutes after drug application

    Time frame: 45 minutes

06

Study locations

1 of 1 sites recruiting
  • Danish Pain Research Center, Aarhus University, Aarhus University Hospital
    Aarhus N, 8200, Denmark
    Recruiting
07

References and documents

Study documents

  • Statistical analysis plan · Mar 1, 2021

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No

08

Registry details

Key details

Study ID
NCT04865185
Lead sponsor
University of Aarhus
Responsible party
Sponsor
First posted
Apr 29, 2021
Start date
Mar 1, 2021
Primary completion
Feb 28, 2022 (estimated)
Completion
Feb 28, 2022 (estimated)
Last update
Apr 29, 2021

Study contacts

Ellen L Schaldemose, MD
Contact
ells@clin.au.dk
+45 93501942
Ellen L Schaldemose, MD
principal investigator · Danish Pain Research Center, Aarhus University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Mar 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion